Fluidigm Corporation Introduces mRNA Sequencing Application for the C1 Single-Cell Auto Prep System
12/19/2012 9:36:11 AM
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today introduced the mRNA sequencing application on its C1™ Single-Cell Auto Prep System. With this new C1 system application, researchers have an easy, end-to-end workflow for detailed transcriptome analysis of 96 single cells to rapidly study differential expression profiles of diverse cell populations. The C1 mRNA Seq Kits and integrated fluidic circuits (IFCs) enable the parallel processing of up to 96 single-cell cDNA libraries for quantitation of mRNA expression on Illumina sequencers. The protocol and reagent kits are expected to be commercially available in January 2013.